ArticleJournal of genetics2022
CircHIPK3 promotes proliferation and metastasis of villous trophoblasts through miR-30a-3p/Wnt2 axis.
Article in Journal of genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 3 citations in OpenAlex.
- MiR-26a-5p/EZH2 Mediates Wnt2 Promoter Methylation to Regulate Trophoblast Dysfunction.Combinatorial chemistry & high throughput screening · 2026Article
- Exosomal miR-494 Regulates the Biological Behavior of Trophoblasts by Targeting mTOR in Unexplained Recurrent Spontaneous Abortion.Molecular biotechnology · 2025Article
- Silencing circRNA-ZFAND6 induces trophoblast apoptosis by activating the mitochondrial pathway through the miR-575/SOD2 axis in unexplained recurrent spontaneous abortion.BMC women's health · 2025Article
- Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects.Journal of experimental & clinical cancer research : CR · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this paper was to explore the role and mechanism of circHIPK3 in unexplained recurrent spontaneous abortion (URSA). The expression of circHIPK3 and miR-30a-3p mRNA in URSA villous tissues was detected by quantitative polymerase chain reaction. The effects of circHIPK3 on the proliferation and migration of villous trophoblasts were analysed by MTTassay and scratch assay. Hoechst/PI staining was used to detect the effect of circHIPK3 on villous trophoblast apoptosis. The binding of circHIPK3 to miR-30a-3p and miR-30a-3p to Wnt2 was analysed by dual-luciferase assay. When URSA occurred, the expression level of circHIPK3 was downregulated, while the expression level of miR-30a-3p was upregulated in villous trophoblasts. Inhibition of circHIPK3 in villous trophoblasts can reduce the proliferation and migration of villous trophoblasts while promoting their apoptosis. The dual-luciferase assay showed that circHIPK3 was able to interact with miR-30a-3p and increased the miR-30a-3p expression after inhibition of circHIPK3, and if miR-30a-3p was also inhibited it was able to reverse the effect of circHIPK3 on villous trophoblast proliferation and migration. It was demonstrated by prediction and dual-luciferase assay that miR-30a-3p binds to Wnt2, and when miR-30a-3p and Wnt2 are inhibited simultaneously, it has an inhibitory effect on the proliferation and migration process of villous trophoblasts. Downregulation of circHIPK3 expression in URSA leads to increased expression of miR-30a-3p, which in turn inhibits the expression of target gene Wnt2 and exerts a weakening effect on the proliferation and migration process of trophoblasts, thereby decreasing trophoblast invasiveness and shallow placental implantation, which in turn leads to recurrent spontaneous abortion.
Indexed as
Identifiers
36560845W4308932725What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.